Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Poland
20 of 22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Bydgoszcz, Warsaw
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - Phase 2Not yet taking people in PolandDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Cracow
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Cracow, Lodz, Rzeszów, Siedlce, Skorzewo
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1/2Not yet taking people in PolandA Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
- Where
- Gdansk, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 198 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07291076 · EU 2025-523602-33-00 - Phase 3Taking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Bialystok, Cracow, Katowice, Lublin, Warsaw
- Age
- 18 years to 99 years
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - Phase 3Taking peoplePhase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Where
- Bydgoszcz, Cracow, Gdansk, Koszalin, Lublin, Olsztyn, Warsaw
- Age
- 18 years and over
- People
- 1,220 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Bydgoszcz, Gdansk, Otwock, Poznan, Wroclaw
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 2Taking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Cracow, Warsaw
- Age
- 18 years and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - Phase 3Taking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Cracow, Koszalin, Lodz, Olsztyn, Warsaw
- Age
- 18 years and over
- People
- 1,100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - Phase 1Taking peopleA Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
- Where
- Brzozów, Koszalin, Lublin, Olsztyn, Przemyśl
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391670 · EU 2025-521639-34-00 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Cracow, Gliwice, Warsaw
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 2Active, not recruitingStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Cracow, Lublin, Otwock, Warsaw
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - Phase 3Taking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Warsaw
- Age
- 18 years and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 - Phase 4Taking peopleHOPE Against Cancer Recurrence in HCC
- Where
- Gdansk, Warsaw
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - No phaseNot yet taking people in Poland15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial
- Where
- Warsaw
- Age
- 18 years and over
- People
- 600
- Run by
- Medical University of Warsaw
See details and how to joinNCT07237204 - Phase 3Taking peopleA clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma
- Where
- Białystok, Bydgoszcz, Gdansk, Katowice, Krakow, Łódź, Lublin, Poznań, Rzeszów, Szczecin, Warsaw, Wrocław, Zabrze
- Age
- Up to 64 years
- People
- 60
- Run by
- Medical University Of Gdansk
See details and how to join2024-514635-26-00 - No phaseTaking peoplectDNA Monitoring in Patients With HCC and mCRC
- Where
- Warsaw
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Medical University of Warsaw
See details and how to joinNCT07001085 - Phase 2Not yet taking people in PolandA Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
- Where
- Koszalin, Warsaw
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Akeso
See details and how to joinNCT06984718 · EU 2025-524591-30-00 - Phase 3Not yet taking people in PolandNamodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- Where
- Koszalin, Krakow, Mysłowice, Przemyśl, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 471 worldwide
- Run by
- Can-Fite BioPharma
See details and how to joinNCT05201404 - No phaseTaking peopleTANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery
- Where
- Warsaw
- Age
- 18 years to 80 years
- People
- 154
- Run by
- Medical University of Warsaw
See details and how to joinNCT06050200